Crossmark

In Silico Drug Repurposing Endorse Amprenavir, Darunavir and Saquinavir to Target Enzymes of Multidrug Resistant Uropathogenic E. Coli

Published Online: 2024-04-26

Published Print: 2024-09

Authors

Halder, Umesh C. https://orcid.org/0000-0002-8913-4624
License Information

Text and Data Mining valid from 2024-04-26

Version of Record valid from 2024-04-26
More Information

Article History

Received: 14 November 2023

Accepted: 5 April 2024

First Online: 26 April 2024

Declarations

:

: The author has no competing interests.

: Not applicable.

: Not applicable.

Document is current